ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea
· Delayed Price · Currency is KRW 160,000
+11,200 (7.53%)
Mar 6, 2026, 3:30 PM KST
ST Pharm Company Description
ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate.
The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics.
It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
ST Pharm Co.,Ltd.
| Country | South Korea |
| Founded | 1983 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 655 |
| CEO | Mooje Sung |
Contact Details
Address: Sihwa Industrial Complex 1na 802 Siheung-si, 15086 South Korea | |
| Phone | 82 3 1488 1300 |
| Website | stpharm.co.kr |
Stock Details
| Ticker Symbol | 237690 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7237690003 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Mooje Sung | Chief Executive Officer |
| YiHwan Kim | Chief Financial Officer |